Erasca, Inc. ERAS
14.25
(0.27)
(1.86%)
as of 25 Sep
- Market cap
- $5.1B
- P/E
- 0.0×
Follow ERAS
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
Current Ratio |
10.04 | 9.84 | 12.26 | 9.13 | 16.02 | 8.77 | 18.59 | — |
Net Debt/EBITDA |
1.93 | 1.61 | 2.16 | 1.77 | 3.34 | 1.09 | 3.60 | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 6.65% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | — |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.77 | 0.68 | 0.81 | 0.43 | 0.65 | 0.32 | 0.86 | — |
Capex/Depreciation |
4.86 | 3.90 | 6.76 | (10.05) | (20.15) | (77.08) | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (33.27%) | (43.68%) | (34.33%) | (55.92%) | (71.68%) | 159.36% | 18.87% | — | |
| (27.72%) | (36.01%) | (27.48%) | (47.78%) | (39.21%) | (112.74%) | (43.38%) | — | |
ROIC |
(179.37%) | (89.66%) | (2,039.97%) | 0.00% | (185.60%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(45.95%) | (55.04%) | (39.46%) | (57.73%) | (29.96%) | (93.99%) | (22.84%) | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Free Cash Flow per Share |
(0.37) | (0.56) | (0.82) | (0.98) | (1.49) | (3.39) | (0.09) | — |
Cash per Share |
0.97 | 1.28 | 2.08 | 3.57 | 6.25 | 5.64 | 0.42 | — |
Shareholders Equity per Share |
1.15 | 1.81 | 2.11 | 3.38 | 6.89 | (5.42) | 0.42 | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
1.15 | 1.81 | 2.11 | 3.38 | 6.89 | (5.42) | 0.42 | — |
Free Cash Flow |
(105.08) | (131.98) | (122.99) | (119.81) | (98.48) | (71.38) | (10.38) | — |
Working Capital |
257.73 | 277.40 | 294.52 | 395.81 | 393.79 | 106.31 | 48.37 | — |
Capital Expenditures |
(9.63) | (22.56) | (21.77) | (16.55) | (18.88) | (38.69) | (0.60) | — |
Net Current Asset Value |
215.26 | 229.77 | 242.07 | 341.44 | 375.13 | (118.82) | 45.41 | — |
| Other line items | ||||||||
Quick Ratio |
9.68 | 9.50 | 11.94 | 8.95 | 15.81 | 8.68 | 18.32 | — |
Depreciation/Fixed assets |
(0.15) | (0.35) | (0.14) | 0.07 | 0.06 | 0.27 | 0.07 | — |
Cash ROIC |
(18.09%) | (17.42%) | (19.64%) | (15.11%) | (10.97%) | (732.10%) | (14.17%) | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,626.02 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(0.34) | (0.47) | (0.67) | (0.85) | (1.20) | (1.55) | (0.09) | — |
Capex per Share |
(0.03) | (0.10) | (0.14) | (0.14) | (0.28) | (1.84) | 0.00 | — |
Average Payables |
0.72 | 1.23 | 12.52 | 13.86 | 2.78 | 1.13 | 1.13 | — |
Average Assets |
449.34 | 448.91 | 455.10 | 508.16 | 313.12 | 90.17 | 27.76 | — |
Average Common Equity |
374.33 | 370.09 | 364.27 | 434.19 | 171.27 | (63.79) | (63.79) | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Columns are period end dates